tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Compugen Reports Q2 2025 Results and Advances in Immuno-Oncology Trials
PremiumCompany AnnouncementsCompugen Reports Q2 2025 Results and Advances in Immuno-Oncology Trials
17d ago
Compugen reports Q2 EPS (8c), consensus (9c)
Premium
The Fly
Compugen reports Q2 EPS (8c), consensus (9c)
17d ago
CGEN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
CGEN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
20d ago
Compugen’s Long-Term Value Potential: Buy Rating Backed by AstraZeneca Partnerships and Financial Stability
PremiumRatingsCompugen’s Long-Term Value Potential: Buy Rating Backed by AstraZeneca Partnerships and Financial Stability
3M ago
Compugen’s Q1 2025: Clinical Progress and Financial Stability
Premium
Company Announcements
Compugen’s Q1 2025: Clinical Progress and Financial Stability
3M ago
Compugen’s Earnings Call: Strategic Shifts and Clinical Advances
Premium
Company Announcements
Compugen’s Earnings Call: Strategic Shifts and Clinical Advances
3M ago
Compugen appoints Eran Ophir as CEO, announces leadership transitions
PremiumThe FlyCompugen appoints Eran Ophir as CEO, announces leadership transitions
3M ago
Compugen’s 2024 Results Highlight Clinical Progress and Financial Stability
Premium
Company Announcements
Compugen’s 2024 Results Highlight Clinical Progress and Financial Stability
6M ago
Compugen’s Earnings Call: A Cautiously Optimistic Outlook
Premium
Company Announcements
Compugen’s Earnings Call: A Cautiously Optimistic Outlook
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100